TrialThe Lancet. Oncology2017
Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial.
Hagop M Kantarjian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
89 papers cite itlatest 60 shown
this paperpooled ittrialcites it